Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Your CSV Timeline Isn’t Failing Because of LIMS — It’s Failing Because People Won’t Follow the Template

When Zamann Pharma Support was hired to support the implementation of LabWare LIMS 8.0 at a Japanese pharmaceutical manufacturer, the mission seemed clear: Define Test Plans to validate system functionalities.

CSV validation delayed due to template modification by users

Guide Key Users to write test cases directly into the official Excel template. Upload test plans into ALM, the system governing approvals and execution of CSV tasks.

But very quickly, we found the real bottleneck:

The validation process was delayed not by technology, but by human resistance. Despite training, guidance, and clear instructions, key users continued to modify the testing templates — altering formatting, deleting validation formulas, adding columns, and breaking auto-numbering — which made each spreadsheet unusable for direct upload into ALM.

The result?

Countless hours of rework, delays in test execution, and blocked approvals. This is exactly how simple resistance leads to months of delay in CSV programs — and nobody sees it until it’s too late.

1. CSV Fails Not Because of Technology — But Because of Behavior

In pharmaceutical projects, we expect CSV challenges to come from complex system configurations, integrations, data flows, or access management.

But one truth is consistently underestimated:

The most common reason CSV timelines fail is human resistance to procedural discipline.

In the Japanese LIMS project, the test template was:

  • Officially approved
  • Aligned with GAMP5
  • Validated and locked for ALM compatibility
  • Explained in training sessions
  • Supported with a written instruction procedure

And still — users changed it every time.

Why?

Because “we prefer our own way of working.”

But in CSV, the “own way” has regulatory consequences.

2. The Hidden Cost of Template Resistance

Each modification to the template created cascading problems across the entire CSV workflow:

Immediate Impacts

  • Broken ALM exports → test plans blocked
  • Manual corrections → increased workload
  • Naming inconsistencies → traceability issues
  • Columns added → formulas failed
  • Approval cycles delayed → execution postponed

Structural Impacts

  • Loss of version control
  • Reduced data integrity
  • Increased risk of findings in inspection
  • QA overwhelmed with document corrections
  • Timeline slippage across all CSV phases

In short, changing a template does not change only one file —

it breaks the entire validation process architecture.

3. Quick Self-Diagnostic: Is This Happening in Your Company?

Give 1 point for every YES.

How many apply to your organization?

  • Question Yes / No Do key users modify CSV templates “to improve them”?
  • Is QA spending more time correcting documents than approving them?
  • Do different departments use different versions of the same CSV template?
  • Does training exist — but behavior doesn’t change?
  • Question Yes / No Does IT sometimes override CSV standards “to save time”?
  • Are test plans delayed due to file inconsistencies?
  • Do validation protocols get approved late because of formatting issues?
  • Are CSV activities reactive instead of controlled?
  • Is ALM or any validation tool overloaded with incorrect uploads?
  • Do project managers struggle to enforce template discipline?

If you scored 5 or more — your CSV process is already at risk, even if your system works.

4. Real Case – The Japanese LIMS Implementation

What Zamann Expected

  • Assist in defining test plans
  • Train key users
  • Ensure ALM compatibility
  • Support CSV documentation flow

What Really Happened

Issue Found Impact

  • Template modification by users ALM rejects test plans
  • Non-standard columns added Traceability lost
  • Local edits saved as final Validation lifecycle broken
  • Version control ignored Document history compromised Formatting changed Upload metadata unreadable
  • Custom colors / merged cells ALM script breaks
  • Manual numbering added Duplicated IDs in execution

Final Result:

A 3-week task turned into 7 weeks of rework — not due to system complexity, but because templates were not respected.

The system was not the problem.

The culture was.

5. Compliance Clarity – What FDA / EMA Expect

Regulators are clear — CSV must follow structured, controlled documentation processes.

Changing templates is not a formatting issue — it is a data integrity risk. Regulation Expectation

  • FDA 21 CFR Part 11 Accuracy, consistency, traceability in validation records
  • EMA Annex 11, §4 Formal documentation structure required
  • GAMP5 Second Edition Standardized templates enforce validation consistency
  • ICH Q9 Human behavior = quality risk factor
  • FDA CSA (2022) Standardization improves assurance & reduces failure points

Outgoing authoritative links:

  • GAMP5 Reference: https://ispe.org/gamp-5
  • FDA Part 11: https://www.fda.gov/regulatory-information/search-fda-guidance documents
  • EMA Annex 11: https://health.ec.europa.eu/system/files/2016-11/annex11_01- 2011_en_0.pdf

Regulatory insight: During inspections, regulators often ask: “Show us your validation template. Show us how it is controlled. Show us how people use it.”

If real use ≠ approved use → compliance risk.

6. What To Do Next – The Action Strategy

To avoid rework, delays, and inspection vulnerabilities, CSV procedures must be operational — not just documented.

Practical Actions to Implement Immediately

  1. 1. Lock templates technically
    • Use password protection
    • Disable column insertion
    • Restrict formatting changes
  2. 2. Include template usage in training AND qualification
    • Ask users to perform sample tests
    • Evaluate adherence — not knowledge
    • Retrain individuals who deviate
  3. 3. Mandate QA review before ALM upload
    • Defined file integrity checklist
    • ALM readiness gateway
  4. 4. Implement template deviation reporting

    If someone changes a template → it must trigger a deviation. After 2 deviations → mandatory retraining.

  5. 5. Define escalation chain

    If consistent template misuse occurs → QA Manager and System Owner must intervene. This is not about policing — it is about lifecycle control.

7. Leadership / Strategy Insight — Compliance Is Culture

A strong template does not guarantee CSV success. A strong culture does.

Technology can be validated.

Processes can be optimized.

But behavior must be led.

CSV maturity is not shown by:

  • The number of documents written
  • The number of tests executed

It is measured by:

How consistently your organization follows its own rules.

In future-ready companies, CSV is not a burden — it becomes a strategic advantage.

In others, it remains an endless cycle of rework.

Which side will your company choose?

Picture of Alireza Zarei

Alireza Zarei

Alireza Zarei is the founder and CEO of Zamann Pharma Support GmbH in Germany. He pairs 20 years in GMP—beginning in a lab in 2005—with front-line global project delivery for companies such as Boehringer Ingelheim, Roche, BioNTech, Takeda, Fresenius Medical Care, Biotest, ratiopharm and others. He focuses on innovative validation and qualification procedures, master data management strategies, end-to-end LIMS implementation and care, with pragmatic advice on general Quality Management topics and management level OpEx consulting. Together with his team he also created Pharmuni.com as the leading GMP learning platform in the industry.